Joseph Vittiglio

Companies

• PepGen Inc.Chief Business & Legal Officer Dec 10, 2025 to now¹
• bluebird bioChief Business & Legal Officer Jan 9, 2023 to now²
• Finch Therapeutics Group, Inc.Chief Business & Legal Officer Dec 21, 2021 to Oct 25, 2022³
• Finch Therapeutics Group, Inc.General counsel Mar 18, 2021 to Mar 18, 2021⁴
• AMAG PharmaceuticalsChief Business Officer, GC Nov 17, 2020 to Nov 17, 2020⁵
• AMAG PharmaceuticalsGeneral counsel Aug 25, 2015 to Mar 12, 2020⁶
• AVEO PHARMACEUTICALS, INC.General counsel Jan 28, 2013 to Jan 8, 2015⁷
• AVEO PHARMACEUTICALS, INC.VP, Chief Corporate Counsel Jun 11, 2012 to Jun 11, 2012⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPepGen Inc. PEPG65,717 shares⁹$174.5K at $2.65Mar 1, 2026
• BBbluebird bio BLUE0 shares¹⁰Jun 2, 2025
• FTFinch Therapeutics Group, Inc.31,364 shares¹¹Oct 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 1, 2026Granted 30,717 shares of PepGen Inc.⁹
• Dec 8, 2025Granted 35,000 shares of PepGen Inc.¹²
• Jun 2, 2025Returned to company 2,500 shares of bluebird bio¹⁰
• Jun 2, 2025Granted 2,500 shares of bluebird bio¹⁰
• Jun 2, 2025Returned to company 3,125 shares of bluebird bio¹⁰
• May 30, 2025U 1,143 shares of bluebird bio¹⁰
• Feb 3, 2025Sold 238 shares at $7.39 of bluebird bio¹³
• Sep 30, 2024Granted 50,000 shares of bluebird bio¹⁴
• Feb 5, 2024Sold 5,217 shares at $0.90 of bluebird bio¹⁵
• Feb 1, 2023Granted 50,000 shares of bluebird bio¹⁶
• Oct 21, 2022Sold 3,636 shares at $1.39 of Finch Therapeutics Group, Inc.¹¹
• Jun 13, 2022Granted 35,000 shares of Finch Therapeutics Group, Inc.¹⁷